Oclacitinib Maleate

CAS : 1640292-55-2

Ref. 3D-QQC29255

Informations sur le produit

• Nom: Oclacitinib Maleate

Description

Oclacitinib Maleate is an orally-bioavailable small molecule drug candidate that inhibits the activity of the protein tyrosine kinase, which is a key signaling molecule in many cancers. Studies have shown that oclacitinib binds to the phosphate group on the ATP-binding site of the enzyme, preventing it from binding to its receptor. Oclacitinib has been shown to be safe and well tolerated for long-term use in diabetic patients. This drug has also been shown to inhibit PDL1 expression and inhibit insulin-like growth factor 1 (IGF1).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 453.51 g/mol
• Formule: C₁₉H₂₇N₅O₆S
• Degré de pureté: Min. 95%